학술논문
Hepatocellular carcinoma presentation and prognosis among Nigerian adults with and without HIV.
Document Type
Article
Author
Davwar, Pantong M.; Okeke, Edith; Duguru, Mary; Nyam, David; Bell, Kristen; Odeghe, Emuobor A.; Oyeleke, Ganiat; Lesi, Olufunmilayo A.; Singh, Revika; Kim, Kwang-Youn; Imade, Godwin; Akanmu, Alani S.; Sagay, Atiene S.; Ogunsola, Folasade T.; Peters, Marion G.; Roberts, Lewis R.; Hou, Lifang; Murphy, Robert L.; Hawkins, Claudia A.
Source
Subject
*NIGERIANS
*CANCER prognosis
*HIV
*HEPATITIS associated antigen
*HEPATITIS B virus
*VIRAL hepatitis
*HEPATITIS C
*
*
*
*
*
*
Language
ISSN
1932-6203
Abstract
Introduction: Hepatocellular carcinoma (HCC) is an increasing cause of mortality in Nigeria among persons with HIV (PLH), as access to antiretroviral therapy (ART) improves. In this study we describe clinical, radiological, and laboratory characteristics in Nigerian adults with HCC, with and without HIV, and examine how HIV impacts survival. Methods: This prospective observational study was conducted between August 2018 and November 2021 at two Nigerian hospitals [Jos University Teaching Hospital (JUTH) and Lagos University Teaching Hospital (LUTH)]. Subjects ≥18 years with HCC diagnosed according to American Association for the Study of Liver Diseases (AASLD) criteria were included. Baseline characteristics were compared, and Kaplan-Meier curves were generated to estimate survival. Results: 213 subjects [177 (83%) without HIV and 36 (17%) with HIV (PLH)] were enrolled. Median age was 52 years (IQR 42,60) and most subjects were male (71%). 83% PLH were on antiretroviral therapy (ART). Hepatitis B surface antigen (HBsAg) positivity was similar between the two groups [91/177 (51%) without HIV vs. 18/36 (50%) with HIV; p = 0.86]. 46/213 (22%) subjects had active hepatitis C (anti-HCV+/HCV RNA>10 IU/mL). Cirrhosis was more common in PLH but there were no other significant differences in clinical and tumor characteristics between the groups. Overall, 99% subjects were symptomatic and 78% in late-stage HCC. Median overall survival was significantly shorter in PLH vs. without HIV (0.98 months vs 3.02 months, HR = 1.55, 95%CI 1.02, 2.37, p = 0.04). This association was not significant after adjusting for known risk factors including gender, current alcohol use, alpha-fetoprotein (AFP), albumin, and total bilirubin (HR = 1.38, 95%CI 0.84, 2.29, p = 0.21). Conclusion: HCC presented late with an extremely poor overall prognosis, highlighting the urgent need for more intensive surveillance in Nigeria to diagnose HCC at earlier stages. Early diagnosis and management of viral hepatitis, and access to HCC therapies, could prevent early mortality among persons with HCC, especially among PLH. [ABSTRACT FROM AUTHOR]